antibody levels – Page 12 – Communicable Diseases Research

Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan

일본의 코로나19 팬데믹 기간 동안 암 환자와 의료 종사자 간의 SARS-CoV-2 항체 상태의 차이

Article

Published on 2021-08-012022-09-11
Journal: JAMA Oncology [Category] MERS, SARS, 진단, 치료법,

Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening

거주 노인에서 mRNA 기반 COVID-19 백신 접종 후 항체 반응: 재개방에 대한 시사점

Article

Published on 2021-08-012022-09-11
Journal: Journal of the American Medical Directors Associat [Category] SARS, 치료기술,

[키워드] adaptive Adults advanced age All participant All participants Analysis anti-SARS-CoV-2 anti-SARS-CoV-2 antibody antibody antibody level antibody levels Antibody Response assisted living B.1.1.7 Beckman Coulter blinded calculated Care coefficients collected Community condition conducted correlated correlation COVID-19 COVID-19 vaccines criteria cross-sectional Descriptive statistics detectable evaluated Factor greater IgG immune response immune responses Immunity Immunoglobulin Impact impair independent independent living Long-term care magnitude males mounted mRNA mRNA-based mRNA-based COVID-19 vaccine Multiple linear regression multiple linear regression analysis neutralization titer neutralization titers nursing homes Older older adult participant Pearson correlation personal care personal care living Pittsburgh protective effect Protective effects provide pseudovirus pseudovirus neutralization titers. Quality improvement reflex reopening response risk SARS-CoV-2 SARS-CoV-2 pseudovirus sera setting Spearman Steroids use of steroids vaccination Variation
[DOI] 10.1016/j.jamda.2021.06.006 PMC 바로가기 [Article Type] Article

Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers

의료 종사자의 AZD1222/Covishield 백신 단일 용량에 대한 면역 반응

Article

Published on 2021-07-292022-09-10
Journal: Nature Communications [Category] SARS, 변종, 진단, 치료기술,

[키워드] ACE2 Adaptive immunity age and gender antibody antibody level antibody levels Antibody titer Antibody titers approval AZD1222 B.1.1.7 B.1.351 B.1.351 variant blocking antibodies carried Cohort COVID-19 vaccine dose ELISpot assay ELISpot assays Ex vivo HCW HCWs Health care Health care worker health care workers Health occupations healthcare worker Healthcare workers IFNγ immunogenicity large cohort naïve Neutralization assay PROTECT RBD Receptor binding domain response SARS-CoV-2 Seroconversion seroconvert seroconverted significantly higher single dose sub-cohort sVNT T cell T cell response the RBD titre titres Vaccine vaccine dose vaccinees Vaccines variant variants wild-type SARS-CoV-2 wild-type virus
[DOI] 10.1038/s41467-021-24579-7 PMC 바로가기 [Article Type] Article

Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals

혈청 양성 및 혈청 형성 개인에서 SARS-CoV-2 mRNA 백신 투여 동안 체액 면역 반응

Research Article

Published on 2021-07-262022-09-01
Journal: BMC Medicine [Category] SARS, 진단,

[키워드] administration antibody antibody level antibody levels Antibody Response Antibody responses Antibody titers approved binding Binding assays BNT162b2 caused comparable coronavirus disease Coronavirus disease 2019 COVID-19 demonstrated dose doses Efficacy epitope Epitopes first vaccination global pandemic guide had no high resolution humoral immune responses IgA IgG IgM antibody immune immune response immune responses immunization immunodominant individual Infection mapped Messenger RNA mRNA mRNA vaccine peptide peptides Pfizer-BioNTech protein antigen regimens Result S1 and S2 SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 neutralizing antibody SARS-CoV-2 spike SARS-CoV-2 spike protein SARS-CoV-2 vaccine SARS-CoV-2 viral SARS-CoV-2 virus seronegative seropositive seropositive individual seropositive individuals significantly higher single dose specificity Spike protein subunit supplementary material Support the antibody response the SARS-CoV-2 the SARS-CoV-2 virus USA vaccination Vaccine Viral viral infection while
[DOI] 10.1186/s12916-021-02055-9 PMC 바로가기 [Article Type] Research Article

Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France

프랑스 북동부 어린이와 성인의 SARS-CoV-2 및 계절성 코로나바이러스에 대한 체액 면역

Research Paper

Published on 2021-07-232022-09-11
Journal: EBioMedicine [Category] MERS, SARS, 임상, 진단,

[키워드] 229E Action adolescents and adults age all age group all age groups antibody antibody level antibody levels Antibody Response Antibody responses Betacoronavirus Biology children collected COVID-19 COVID-19 pandemic cross-protective immunity cross-reactivity cross-sectional disease Emerging infectious diseases European Evidence finding France French funding HCoV highest HKU1 Horizon Hospital admission human coronavirus Immunity immunoassays individuals infected individuals Infection infection with SARS-CoV-2 infections Infectious disease Infectious diseases large cohort levels of antibody lowest luciferase Multiplex assay neutralisation assay NL63 Non-COVID-19 observé OC43 pseudotype Research SARS-CoV-2 SARS-CoV-2 infected individual SARS-CoV-2 infected individuals SARS-COV-2 infection SARS-CoV-2 spike SARS-CoV-2-specific antibodies SARS-CoV-2-specific antibody seasonal coronavirus seasonal coronaviruses Sero-epidemiology seronegative seropositive individual seropositive individuals Seroprevalence serum sample serum samples severity specific antibodies specific antibody spike supported union unit were assessed
[DOI] 10.1016/j.ebiom.2021.103495 PMC 바로가기 [Article Type] Research Paper

Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom

영국 총 인구에서 45,965 명의 SARS-COV-2 백신에 대한 항체 반응

Clinical Trial

Published on 2021-07-212022-08-13
Journal: Nature Microbiology [Category] Fulltext, SARS, 임상, 진단,

Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients

무증상 및 가벼운 질병의 조기 및 장기 항체 동역학 COVID-19 환자

Article

Published on 2021-07-022022-09-01
Journal: Scientific Reports [Category] SARS, 임상, 진단, 치료기술,

[키워드] Accuracy acute infection analyzed antibody antibody kinetics antibody levels association Asymptomatic can be used Clinical symptoms Cluster collected Confirmed COVID-19 patient decay Decision tree defined disease Epidemiology evaluated household contact IgM antibodies infected with SARS-CoV-2 Infectious diseases Inflammatory Mild Most patient Most patients Patient peak predict SARS-CoV-2 patient Seroconversion serological serology analysis seropositive serum antibodies serum antibody serum sample serum samples significantly Study participants Symptom symptomatic Symptoms the disease Viral Viral load
[DOI] 10.1038/s41598-021-93175-y PMC 바로가기 [Article Type] Article

Severe acute respiratory syndrome coronavirus 2 serology levels in pregnant women and their neonates

임산부와 신생아의 중증 급성 호흡기 증후군 코로나바이러스 2 혈청학적 수치

Article

Published on 2021-07-012022-09-11
Journal: American journal of obstetrics and gynecology [Category] SARS, 진단, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Affect Analysis antibody antibody levels Asymptomatic asymptomatic infection baby Birth characterized conducted convalescent convalescent infection Cord blood coronavirus coronavirus disease Coronavirus disease 2019 Course COVID-19 COVID-19 infection demonstrated dependent on determine disease severity hospital identify immune response immune system Immunity Immunoglobulin Immunoglobulin G immunoglobulin M inclusion criteria Infection Linear regression Local log marker maternal antibodies maternal antibody mother mother-baby dyads Multiple linear regression multiple linear regression analysis Neonatal Neonate Neonates New York City oxygen oxygen support passive immunity Patient patient cohort Pearson correlation Population positive predicted Predictive predictor pregnant women Prevalence Quantitative respiratory responses retrospective serologic antibody Serologic response serology severe acute respiratory syndrome Coronavirus subset susceptible Symptom symptom onset symptomatic symptomatic and asymptomatic symptomatic and asymptomatic patients symptomatic infection Symptoms T Test tested the timing These data time course Umbilical cord umbilical cord blood Vaccination strategies viral infections Vulnerable populations women
[DOI] 10.1016/j.ajog.2021.01.016 PMC 바로가기 [Article Type] Article

Evaluation of the IgG antibody response to SARS CoV-2 infection and performance of a lateral flow immunoassay: cross-sectional and longitudinal analysis over 11 months

SARS CoV-2 감염에 대한 IgG 항체 반응 평가 및 측방 유동 면역 분석의 성능: 11개월에 걸친 횡단면 및 종단 분석

Article

Published on 2021-06-292022-09-11
Journal: BMJ Open [Category] MERS, SARS, 진단, 치료기술, 치료제,

[키워드] Abbott Abbott SARS-CoV-2 IgG anti-SARS-CoV-2 antibody antibody levels Blood Blood donations Cohort collected comprehensive analysis convalescent plasma COVID-19 cross-sectional detectable diagnostic Diagnostic microbiology diagnostics Donor Elecsy Elecsys ELISA Euroimmun evaluate healthcare worker humoral immune response IgG IgG antibodies IgG antibody immunoassay immunoassays individual individuals Infection Ireland Laboratory lateral flow lateral flow immunoassay LFIA Longevity longitudinal analysis minimum molecular molecular diagnostics outcome pandemic Performance metrics persistence plasma sample plasma samples positive Post-infection post-symptom onset Rapid Rapid test Research Roche SARS CoV-2 SARS-CoV-2 antibody SARS-CoV-2 ELISA SARS-CoV-2 IgG SARS-CoV-2 IgG antibodies SARS-CoV-2 IgG antibody SARS-COV-2 infection SARS-CoV-2 spike protein sensitivity Sensitivity and specificity serological specificity Spike protein Test
[DOI] 10.1136/bmjopen-2020-048142 PMC 바로가기 [Article Type] Article

Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19

Covid-19 후 최대 12.5 개월까지 의료 종사자의 혈청 양성 및 재감염의 지속성 및 기준 결정 요인

Correspondence

Published on 2021-06-282022-09-01
Journal: BMC Medicine [Category] MERS, SARS, 진단, 치료기술,

[키워드] allergies Anosmia anosmia/hypogeusia antibodies antibody antibody level antibody levels Antibody Response Antibody responses Antigen baseline Baseline determinants Care Cohort correlated COVID-19 COVID-19 symptom COVID-19 symptoms COVID-19 vaccine determinant domain Duration Fever first episode Health Health care Health care worker health care workers Hope Hospitalization Hypogeusia IgA IgG IgG response IgG responses IgM Immunity individual Kinetics long-lasting Occurrence Patient Primary Health Care prospective cohort raise Reinfection SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 spike antigen seronegative Seropositivity significantly smoking Spanish Spike antigen STABLE subset supplementary material symptoms onset
[DOI] 10.1186/s12916-021-02032-2 PMC 바로가기 [Article Type] Correspondence